Status:
RECRUITING
Investigating Visual Verticality Disorder and Lateropulsion in a Neurosurgical Cohort of Patients With Brain Tumours
Lead Sponsor:
The University of Western Australia
Collaborating Sponsors:
Sir Charles Gairdner Hospital
University of Sao Paulo
Conditions:
Brain Tumours
Eligibility:
All Genders
18-80 years
Brief Summary
The overall objective of this research is to investigate the clinical characteristics pre- and post-brain tumour resection with a focus on visual verticality disorder, and lateropulsion, including neu...
Detailed Description
Visual verticality perception disorder is the inability to judge the orientation of a vertical line or environment in relation to the Earth's vertical within normal limits, a critical symptom that aff...
Eligibility Criteria
Inclusion
- Patients of age 18 to 80 admitted to SCGH under the neurosurgery team with a confirmed diagnosis of a brain tumour.
- Only patients who undergo partial or full brain tumour resection and are medically stable.
- Able to provide written informed consent or consent provided by a Research Decision-Maker with the approval of an Independent Medical Practitioner (IMP) as per the Guardianship and Administration Act 1990 (GAA).
- Patients with a support network that enables them to accommodate to travel commitments for assessments if travel to the hospital is required.
Exclusion
- Patients who undergo only biopsy will not be included.
- Unable to follow any instructions and complete assessments due to significant medical deterioration.
- Patients who are pregnant.
- Current diagnosis of COVID-19 or respiratory syncytial virus (RSV), or any type of influenza.
- Patients without a support network that enables them to accommodate to travel commitments for assessments if travel to the hospital is required.
- An Advanced Care Health Directive prohibiting decision making by Research Decision-Maker.
Key Trial Info
Start Date :
June 12 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06951659
Start Date
June 12 2025
End Date
December 30 2025
Last Update
June 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sir Charles Gairdner Osborne Park Health Care Group
Perth, Western Australia, Australia, 6009